MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Genetic testing in pediatric dystonia and influence of clinical factors on diagnostic yield

T. Larsh, H. Fernandez, M. Aldosari (Cleveland, OH, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 132

Keywords: Dopa-responsive dystonia(DRD), Dystonia: Etiology and Pathogenesis, Dystonia: Genetics

Category: Dystonia: Epidemiology, Genetics, Phenomenology

Objective: To identify the yield of genetic testing in suspected genetically determined pediatric dystonia. Identify differences in clinical factors among patients with confirmatory and non-confirmatory genetic testing.

Background: Pediatric dystonia is frequently part of a complex neurodevelopmental disorder, often due to an underlying genetic etiology. The yield of genetic testing and factors influencing diagnostic yield in pediatric dystonia have not been reported to date.

Method: We retrospectively reviewed the electronic medical records of pediatric patients with dystonia evaluated at our center between 2016 and 2019 and identified patients who had genetic testing done as part of their evaluation for a suspected genetic etiology. We identified initial presenting symptomatology, exam findings, details of genetic testing, and time from initial symptom to diagnosis in patients with a confirmed genetic diagnosis.

Results: We identified thirty-nine pediatric dystonia patients with genetic testing. Genetic testing confirmed a genetic diagnosis in 53.8% of patients. Yield of confirming a diagnosis with genetic testing was as follows: chromosomal microarray (n=18): 11.1%; single gene testing (n=10): 30%; gene panel testing (n=17): 23.5%; whole exome sequencing (n=14): 57.1%; and mitochondrial genomic sequencing (n=10): 50%. Compared to patients with non-confirmatory genetic testing, patients with confirmatory genetic testing more often presented with developmental regression/cognitive decline (33.3% versus 5.6%, p=0.032) or gait/balance complaints (76.2% versus 38.9%, p=0.018) and more often had gait/balance abnormalities on exam (57.1% versus 22.2%, p=0.027). Average time to confirmatory diagnosis was 3.4 years from initial symptom onset.

Conclusion: We report confirming a genetic etiology in 53.8% of pediatric patients presenting with dystonia of suspected genetic etiology. This information may help inform future treatment decisions and patient counseling. The presence of certain co-occurring clinical factors may help predict the likelihood that testing will confirm a genetic etiology.

Confirmatory v nonconfirmatory table

yield of genetic testing

To cite this abstract in AMA style:

T. Larsh, H. Fernandez, M. Aldosari. Genetic testing in pediatric dystonia and influence of clinical factors on diagnostic yield [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/genetic-testing-in-pediatric-dystonia-and-influence-of-clinical-factors-on-diagnostic-yield/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/genetic-testing-in-pediatric-dystonia-and-influence-of-clinical-factors-on-diagnostic-yield/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley